<DOC>
	<DOC>NCT03065985</DOC>
	<brief_summary>This study will assess if endoscopic ultrasound radiofrequency application in patients with inoperable pancreatic cancer and chemotherapy confers survival benefit when compared to patients receiving best medical care and chemotherapy .</brief_summary>
	<brief_title>EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma.</brief_title>
	<detailed_description>Prospective randomised clinical study in patients with adenocarcinoma of the pancreas. Patients will be randomised 1:1. Patients in the treatment group will receive standard chemotherapy plus 3 radiofrequency ablation procedures, each one month apart. Patients in the control group will receive standard chemotherapy and best medical care.</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Patients above 18 years of age A cytological/ histological diagnosis of inoperable PDAC based on multidisciplinary review of crosssectional imaging and cytology/ histology results. Patients who have been deemed unfit for surgical resection of the PDAC; subjects who are fit for surgical resection, but have declined surgery will also be considered for the study PDAC patients presenting with jaundice to be considered after a successful biliary drainage (bilirubin &lt;50umol/L) Patients ought to be fit enough to be considered for the study (ECOG performance status 0, 1 or 2) Patients who have commenced chemotherapy are not excluded from the study Patients capable of giving informed consent Negative blood pregnancy test for women of childbearing potential Willingness and ability to comply with all protocol requirements including scheduled visits, treatment plans, laboratory tests and other study procedures. ECOG performance status 3 or 4 Life expectancy less than 3 months Prior investigational drugs within the last 30 days Grade &gt; 1 treatmentrelated toxicities (excluding alopaecia) at the time of screening Patients with clinically significant cancer ascites Known infection with human immunodeficiency virus (HIV) Patient with central nervous system (CNS) metastasis Major surgery within the last 30 days Patients with sepsis, obstructive jaundice or encephalopathy Evidence of spontaneous bacterial peritonitis or renal failure Pregnant or lactating women Any other condition (e.g., known or suspected poor compliance, etc.) that, in the judgment of the investigator, may affect the participant's ability to follow the protocol specific procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>